CONVERT: Concurrent ONce-daily VErsus twice-daily RadioTherapy. A new phase III randomised controlled trial for patients LS SCLC and good performance status

被引：0
|
作者：
Faivre-Finn, C. [1 ]
Flight, H. [1 ]
机构：
[1] Christie Hosp, Manchester, Lancs, England
来源：
LUNG CANCER | 2008年 / 60卷
关键词：
D O I：
10.1016/S0169-5002(08)70010-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9
引用
收藏
页码：S3 / S4
页数：2
相关论文
共 50 条
  • [1] CONVERT: Concurrent Once-Daily Versus Twice-Daily Radiotherapy - a phase III randomised controlled trial for patients with LS SCLC and good performance status
    Faivre-Finn, C.
    Falk, S.
    LUNG CANCER, 2011, 71 : S40 - S41
  • [2] CONVERT: Concurrent ONce-daily VErsus twice-daily RadioTherapy. A phase III randomised controlled trial for patients with limited stage small cell lung cancer (LS-SCLC) and good performance status
    Faivre-Finn, C.
    Falk, S.
    LUNG CANCER, 2012, 75 : S55 - S55
  • [3] CONVERT: Concurrent once-daily versus twice-daily radiotherapy - A phase III randomised controlled trial for patients with limited stage small cell lung cancer and good performance status
    Faivre-Finn, C.
    LUNG CANCER, 2010, 67 : S11 - S11
  • [4] CONVERT. Concurrent once-daily versus twice-daily radiotherapy - a new phase III randomised controlled trial for patients with limited-stage small cell lung cancer and good performance status
    Faivre-Finn, C.
    Falk, S.
    LUNG CANCER, 2009, 63 : S12 - S12
  • [5] Protocol for the CONVERT trial-Concurrent ONce-daily VErsus twice-daily Radio Therapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status
    Faivre-Finn, Corinne
    Falk, Sally
    Ashcroft, Linda
    Bewley, Michelle
    Lorigan, Paul
    Wilson, Elena
    Groom, Nicki
    Snee, Michael
    Fournel, Pierre
    Cardenal, Felipe
    Bezjak, Andrea
    Blackhall, Fiona
    BMJ OPEN, 2016, 6 (01):
  • [6] Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial
    Christodoulou, Marianna
    Blackhall, Fiona
    Mistry, Hitesh
    Leylek, Ahmet
    Knegjens, Joost
    Remouchamps, Vincent
    Martel-Lafay, Isabelle
    Farre, Nuria
    Zwitter, Matjaz
    Lerouge, Delphine
    Pourel, Nicolas
    Janicot, Henri
    Scherpereel, Arnaud
    Tissing-Tan, Caroline
    Peignaux, Karin
    Geets, Xavier
    Konopa, Krzysztof
    Faivre-Finn, Corinne
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (01) : 63 - 71
  • [7] Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily versus Twice-Daily RadioTherapy (CONVERT) Trial
    Christodoulou, Marianna
    Blackhall, Fiona
    Ashcroft, Linda
    Leylek, Ahmet
    Knegjens, Joost
    Remouchamps, Vincent
    Martel-Lafay, Isabelle
    Farre, Nuria
    Zwitter, Matjaz
    Lerouge, Delphine
    Pourel, Nicolas
    Janicot, Henri
    Scherpereel, Arnaud
    Tissing-Tan, Caroline
    Peignaux, Karine
    Geets, Xavier
    Konopa, Krzysztof
    Faivre-Finn, Corinne
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S262 - S263
  • [8] CONVERT - An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS)
    Faivre-Finn, C.
    Snee, M.
    Ashcroft, L.
    Appel, W.
    Barlesi, F.
    Bhatnagar, A.
    Bezjak, A.
    Cardenal, F.
    Fournel, P.
    Harden, S.
    Le Pechoux, C.
    McMenemin, R.
    Mohammed, N.
    O'Brien, M.
    Pantarotto, J.
    Surmont, V.
    Van Meerbeeck, J.
    Woll, P.
    Lorigan, P.
    Blackhall, F.
    LUNG CANCER, 2017, 103 : S64 - S64
  • [9] CONVERT: An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS).
    Faivre-Finn, Corinne
    Snee, Michael
    Ashcroft, Linda
    Appel, Wiebke
    Barlesi, Fabrice
    Bhatnagar, Adityanarayan
    Bezjak, Andrea
    Cardenal, Felipe
    Fournel, Pierre
    Harden, Susan
    Le Pechoux, Cecile
    McMenemin, Rhona Margaret
    Mohammed, Nazia
    O'Brien, Mary E. R.
    Pantarotto, Jason R.
    Surmont, Veerle
    Van Meerbeeck, Jan
    Woll, Penella J.
    Lorigan, Paul
    Blackhall, Fiona Helen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Patient-reported toxicity in twice-daily (BID) versus once-daily (OD) chemoradiotherapy for LS-SCLC
    Lodeweges, J.
    Niezink, A.
    Elzinga, H.
    Haan-Stijntjes, E.
    Dollekamp, N.
    Chouvalova, O.
    Ubbels, J.
    Woltman-van Iersel, M.
    Van der Leest, A.
    Langendijk, J.
    Widder, J.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S664 - S665
12345